摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-fluorophenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine hydrochloride | 1575612-05-3

中文名称
——
中文别名
——
英文名称
2-(4-fluorophenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine hydrochloride
英文别名
2-(4-Fluorophenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine;hydrochloride
2-(4-fluorophenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine hydrochloride化学式
CAS
1575612-05-3
化学式
C12H12FN3*ClH
mdl
——
分子量
253.707
InChiKey
XGXRNSFBMRJKFR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.21
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    29.8
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    2-(4-fluorophenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine hydrochloride1-(((2R,3S),2-(2,4-二氟苯基)-3-甲基环氧乙烷-2-基)甲基)-1H-1,2,4-三唑乙腈 为溶剂, 反应 24.0h, 以41.2%的产率得到(2R,3R)-2-(2,4-difluorophenyl)-3-(2-(4-fluorophenyl)-5,6-dihydroimidazo[1,2-a]piperazine-7(8H)-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
    参考文献:
    名称:
    Design, Synthesis, and Structure–Activity Relationship Studies of Novel Fused Heterocycles-Linked Triazoles with Good Activity and Water Solubility
    摘要:
    Triazoles with fused-heterocycle nuclei were designed and evaluated for their in vitro activity on the basis of the binding mode of albaconazole using molecular docking, along with SAR of antifungal triazoles. Tetrahydro-[1,2,4]-triazolo[1,5-a]pyrazine and tetrahydro-thiazolo[5,4-c]pyridine nuclei were preferable to the other four fused-heterocycle nuclei investigated. Potent in vitro activity, broad spectrum and better water solubility were attained when triazoles containing nitrogen aromatic heterocycles were attached to these two nuclei. The most potent compounds 27aa and 45x, with low hERG inhibition and hepatocyte toxicity, both exhibited excellent activity against Candida, Cryptococcus, and Aspergillus spp., as well as selected fluconazole-resistant strains. A high water-soluble compound 58 (the disulfate salt of 45x) displayed unsatisfactory in vivo activity because of its poor PK profiles. Mice infected with C.alb. SC5314 and C.alb. 103 (fluconazole-resistant strain) and administered with 27aa displayed significantly improved survival rates. 27aa also showed favorable pharmacokinetic (PK) profiles.
    DOI:
    10.1021/jm4016284
  • 作为产物:
    描述:
    4-氟苯乙酮 在 palladium on activated charcoal 、 氢气溶剂黄146 作用下, 以 甲醇 为溶剂, 15.0~50.0 ℃ 、344.75 kPa 条件下, 反应 36.33h, 生成 2-(4-fluorophenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine hydrochloride
    参考文献:
    名称:
    EP3252059
    摘要:
    公开号:
点击查看最新优质反应信息

文献信息

  • ANTI-PULMONARY TUBERCULOSIS NITROIMIDAZOLE DERIVATIVE
    申请人:Medshine Discovery Inc.
    公开号:EP3252059A1
    公开(公告)日:2017-12-06
    Disclosed is a substituted nitroimidazole derivative, which is mainly used for treating related diseases caused by mycobacterial infections, such as Mycobacterium tuberculosis, especially being suitable for diseases caused by resistant Mycobacterium tuberculosis.
    本发明公开了一种取代的硝基咪唑生物,主要用于治疗结核分枝杆菌等分枝杆菌感染引起的相关疾病,尤其适用于耐药结核分枝杆菌引起的疾病。
  • Anti-pulmonary tuberculosis nitroimidazole derivative
    申请人:MEDSHINE DISCOVERY INC.
    公开号:US10227362B2
    公开(公告)日:2019-03-12
    Disclosed is a substituted nitroimidazole derivative, which is mainly used for treating related diseases caused by mycobacterial infections, such as Mycobacterium tuberculosis, especially being suitable for diseases caused by resistant Mycobacterium tuberculosis.
    本发明公开了一种取代的硝基咪唑生物,主要用于治疗结核分枝杆菌等分枝杆菌感染引起的相关疾病,尤其适用于耐药结核分枝杆菌引起的疾病。
查看更多